TY - JOUR
T1 - Mortality under plausible interventions on antiretroviral treatment and depression in HIV-infected women
T2 - an application of the parametric g-formula
AU - WIHS Investigators
AU - WIHS Investigators
AU - Lesko, Catherine R.
AU - Todd, Jonathan V.
AU - Cole, Stephen R.
AU - Edmonds, Andrew
AU - Pence, Brian W.
AU - Edwards, Jessie K.
AU - Mack, Wendy J.
AU - Bacchetti, Peter
AU - Rubtsova, Anna
AU - Gange, Stephen J.
AU - Adimora, Adaora A.
AU - Saag, Michael
AU - Kempf, Mirjam Colette
AU - Konkle-Parker, Deborah
AU - Ofotokun, Ighovwerha
AU - Wingood, Gina
AU - Anastos, Kathryn
AU - Minkoff, Howard
AU - Gustafson, Deborah
AU - Cohen, Mardge
AU - French, Audrey
AU - Young, Mary
AU - Kassaye, Seble
AU - Fischl, Margaret
AU - Metsch, Lisa
AU - Adimora, Adaora
AU - Greenblatt, Ruth
AU - Aouizerat, Bradley
AU - Tien, Phyllis
AU - Golub, Elizabeth
AU - Milam, Joel
N1 - Publisher Copyright:
© 2017 Elsevier Inc.
PY - 2017/12
Y1 - 2017/12
N2 - Purpose Among HIV-infected persons, antiretroviral therapy (ART) and depression are strongly associated with mortality. We estimated reductions in 5-year mortality in Women's Interagency HIV Study participants under plausible hypothetical increases in ART initiation and reductions in depression (CES-D score≥16). Methods We followed 885 ART-naïve Women's Interagency HIV Study participants for 5 years from their first study visit after April 1998 to death or censoring. We used the parametric extended g-formula to estimate cumulative mortality under the natural course (NC) and alternative exposure distributions. Results Baseline prevalence of depression was 52% and 62% initiated ART by 5 years. Compared with mortality under NC (13.2%), immediate ART and elimination of 36% or 67% of depressive episodes were associated with risk differences (RDs) of −5.2% (95% CI: −7.7%, −2.6%) and −5.7 (95% CI: −8.7, −2.7). Compared with immediate ART and NC for depression, additionally eliminating 67% of the depressive episodes was associated with RD = −1.6 (95% CI: −3.9, 0.8). Compared with 5-year mortality under NC for ART and elimination of 67% of depression, also initiating ART immediately was associated with RD = -2.6 (95% CI: -5.0, -0.3). Conclusions Increasing ART initiation and reducing depression were associated with moderate reductions in 5-year mortality among HIV-infected women.
AB - Purpose Among HIV-infected persons, antiretroviral therapy (ART) and depression are strongly associated with mortality. We estimated reductions in 5-year mortality in Women's Interagency HIV Study participants under plausible hypothetical increases in ART initiation and reductions in depression (CES-D score≥16). Methods We followed 885 ART-naïve Women's Interagency HIV Study participants for 5 years from their first study visit after April 1998 to death or censoring. We used the parametric extended g-formula to estimate cumulative mortality under the natural course (NC) and alternative exposure distributions. Results Baseline prevalence of depression was 52% and 62% initiated ART by 5 years. Compared with mortality under NC (13.2%), immediate ART and elimination of 36% or 67% of depressive episodes were associated with risk differences (RDs) of −5.2% (95% CI: −7.7%, −2.6%) and −5.7 (95% CI: −8.7, −2.7). Compared with immediate ART and NC for depression, additionally eliminating 67% of the depressive episodes was associated with RD = −1.6 (95% CI: −3.9, 0.8). Compared with 5-year mortality under NC for ART and elimination of 67% of depression, also initiating ART immediately was associated with RD = -2.6 (95% CI: -5.0, -0.3). Conclusions Increasing ART initiation and reducing depression were associated with moderate reductions in 5-year mortality among HIV-infected women.
UR - http://www.scopus.com/inward/record.url?scp=85029567856&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85029567856&partnerID=8YFLogxK
U2 - 10.1016/j.annepidem.2017.08.021
DO - 10.1016/j.annepidem.2017.08.021
M3 - Article
C2 - 28939001
AN - SCOPUS:85029567856
SN - 1047-2797
VL - 27
SP - 783-789.e2
JO - Annals of Epidemiology
JF - Annals of Epidemiology
IS - 12
ER -